Novel Protein May Help Detect Lou Gehrig’s Disease and Dementia
February 12, 2013
Mayo Clinic researchers have discovered an abnormal protein that accumulates in the brains of many patients affected with two common neurodegenerative disorders — amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease, and frontotemporal dementia. They say their findings have uncovered a potentially new therapeutic target and biomarker that would allow clinicians to confirm diagnosis of the diseases. The study is published online in the journal Neuron.
Click here for news release